Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Stephanie Wernick"'
Autor:
Thomas Prukop, Jan Stenzel, Stephanie Wernick, Theresa Kungl, Magdalena Mroczek, Julia Adam, David Ewers, Serguei Nabirotchkin, Klaus-Armin Nave, Rodolphe Hajj, Daniel Cohen, Michael W Sereda
Publikováno v:
PLoS ONE, Vol 14, Iss 1, p e0209752 (2019)
The most common type of Charcot-Marie-Tooth disease is caused by a duplication of PMP22 leading to dysmyelination, axonal loss and progressive muscle weakness (CMT1A). Currently, no approved therapy is available for CMT1A patients. A novel polytherap
Externí odkaz:
https://doaj.org/article/54beea3e92d54d269e68e88861e3c885
Autor:
Serguei Nabirotchkin, Lydie Boussicault, Dirk Czesnik, Susanne Quintes, Jana Zschüntzsch, Jens Schmidt, Julia Adam, David Ewers, Michael Bartl, Daniel Cohen, Julien Laffaire, Karoline Jäger, Klaus-Armin Nave, Anthony Brureau, Markus H. Schwab, Alonso Barrantes-Freer, Stephanie Wernick, Michael W. Sereda, Philippe Rinaudo, Thomas Prukop, Gwenaël Primas, Lorenz Winter, Rodolphe Hajj, Lisa Linhoff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::445691622dcc0db7869b1ef4b553b8af
https://doi.org/10.1002/jnr.24679/v2/response1
https://doi.org/10.1002/jnr.24679/v2/response1
Autor:
Daniel Cohen, Jan Stenzel, Magdalena Mroczek, Rodolphe Hajj, Serguei Nabirotchkin, Theresa Kungl, Klaus-Armin Nave, Julia Adam, Stephanie Wernick, Michael W. Sereda, Thomas Prukop, David Ewers
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 1, p e0209752 (2019)
PLoS One
PLoS ONE, Vol 14, Iss 1, p e0209752 (2019)
PLoS One
The most common type of Charcot-Marie-Tooth disease is caused by a duplication of PMP22 leading to dysmyelination, axonal loss and progressive muscle weakness (CMT1A). Currently, no approved therapy is available for CMT1A patients. A novel polytherap